Search

Displaying results 2311 - 2320 of 8967 in total
  1. Indication

    Alveolitis, Extrinsic Allergic

    go.drugbank.com/conditions/DBCOND0115831
    Drugs: Prednisolone · Prednisone
    Synonyms: Hypersensitivity pneumonitis due to unspecified organic dust
  2. Indication

    Myelofibroses

    go.drugbank.com/conditions/DBCOND0092673
    Drugs: Fedratinib · Oxymetholone · Ruxolitinib
    Synonyms: Myelofibrosis due to another disorder (disorder)
  3. Indication

    Pneumonia, Pneumocystis Jerovici

    go.drugbank.com/conditions/DBCOND0070467
    Drugs: Atovaquone · Clindamycin · Fluorescein · Pentamidine · Prednisolone · Prednisone +4 more
    Synonyms: Pneumonia due to Pneumocystis carinii
  4. Drug

    Phenyltoloxamine

    go.drugbank.com/drugs/DB11160
    Approved

    Phenyltoloxamine citrate is the more common salt form that acts as an active ingredient in pharmaceutical products and promotes hay fever relief via reversing the effects of histamine. … Although phenyltoloxamine's ability to potentiate the effects of analgesics may be explained in part by its chemical nature as a first-generation H1 antihistamine that is capable of crossing the blood-brain

  5. Drug

    Lopinavir

    go.drugbank.com/drugs/DB01601
    ApprovedInvestigational

    [A191757] Lopinavir was previously under investigation in combination with ritonavir for the treatment of COVID-19 caused by SARS-CoV-2.[L12012] … Ritonavir is a potent inhibitor of the enzymes responsible for lopinavir metabolism, and its co-administration "boosts" lopinavir exposure and improves antiviral activity.

    Categories: Antivirals for Systemic Use, Antiinfectives for Systemic Use
  6. Drug

    Raloxifene

    go.drugbank.com/drugs/DB00481
    ApprovedInvestigational

    However, due to the off-target actions by HRT, newer non-hormonal agents such as raloxifene and [tamoxifen] have been developed to reduce adverse events through selective pharmacological actions on tissue-specific … [A4977] Available in many countries worldwide, raloxifene was initially approved by the FDA in December, 1997 under the market name Evista® for the management and prevention of osteoporosis in postmenopausal

  7. Indication

    Chronic Phase Chronic Myeloid Leukemia

    go.drugbank.com/conditions/DBCOND0057382
    Drugs: Asciminib · Bosutinib · Dasatinib · Daunorubicin · Nilotinib · Ponatinib
    Synonyms: Chronic myelogenous leukemia, no International Classification of Diseases for Oncology subtype
  8. Drug

    Felodipine

    go.drugbank.com/drugs/DB01023
    Approved

    Felodipine is used to treat mild to moderate essential hypertension. … In addition to binding to L-type calcium channels, felodipine binds to a number of calcium-binding proteins, exhibits competitive antagonism of the mineralcorticoid receptor, inhibits the activity of calmodulin-dependent

    Categories: Antihypertensive Agents Indicated for Hypertension
  9. Drug

    Urea C-14

    go.drugbank.com/drugs/DB09513
    ApprovedInvestigational

    To detect H. pylori, urea labeled with 14C is swallowed by the patient. … The UBT is indicated to confirm H. pylori infection and to monitor post-treatment for its eradication. Radiolabelled urea is available in two forms as 13C and 14C.

  10. Drug

    Daprodustat

    go.drugbank.com/drugs/DB11682
    ApprovedInvestigational

    anemia of CKD but not for non-dialysis patients with anemia of CKD. … [A254167,A254162] Patients with CKD cannot induce erythropoietin (EPO) production in response to hypoxia or anemia.